← Human Trials & Peer-Reviewed Studies
Vitamin D Status and Longitudinal Changes in Body Composition in Patients with Chronic Obstructive Pulmonary Disease - A Prospective Observational Study.
Plain-language guide to PMID 38895044 (2024): observational study of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 38895044
- Journal
- International journal of chronic obstructive pulmonary disease
- Year
- 2024
- Study type
- Observational Study
- Authors
- Minter M et al. (7 authors)
- DOI
- 10.2147/COPD.S458102
What This Study Did, in Plain Language
What Was Tested
This observational study looks at Vitamin D, K2, Magnesium and Zinc.
This study aimed to evaluate the association between vitamin D levels and status with body composition (BC), as well as with its changes over time.
Multiple linear regression analyses were performed to assess the relationships between 25(OH)D (nmol/l) and longitudinal changes in BMI, fat-free mass index (FFMI), fat mas index (FMI) and bone mineral density (BMD).
Why It Was Studied
Alterations in body weight and composition are common in patients with chronic obstructive pulmonary disease (COPD) and are independent predictors for morbidity and mortality.
Low vitamin D status is also more prevalent in patients with COPD compared to controls and has been related to lower lung function, muscle atrophy and impaired musculoskeletal function.
Who Took Part
By PubMed's age tags, the people studied were middle-aged adults and older adults, both men and women.
Patients with COPD and controls without COPD, participating in the Individualized COPD Evaluation in relation to Ageing (ICE-Age) study, a prospective observational study, were included.
What Was Measured
The subject headings attached to it are Pulmonary Disease, Chronic Obstructive, Vitamin D, Bone Density, Vitamin D Deficiency, Body Composition, Absorptiometry, Photon and Lung.
The authors tagged it with the keywords bone mineral density, chronic obstructive pulmonary disease, fat-free mass and longitudinal changes.
What This Means in Plain Language
This is an observational study of Vitamin D, K2, Magnesium and Zinc.
Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2024 (International journal of chronic obstructive pulmonary disease), a journal based in New Zealand.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.